Biomarkers show difference between healthy, obese kids; Personalized medicine market to grow;

> Biomarkers show metabolic differences between healthy and obese 7- to 9-year-olds. "The substantial variation in biomarkers we observed in these young children suggests that obesity in this age group may disrupt normal metabolism, impairing glucose tolerance and increasing the risk for Type 2 diabetes later in life," says Louisiana State's Melinda Sothern. More here

> Waters Corp. has recognized the Center for Proteomics at the Translational Genomics Research Institute in Phoenix as a Waters Center of Innovation. One of TGen's "core strengths" is in biomarker discovery and verification. Release

> PricewaterhouseCoopers expects the market for personalized medicine to grow 11% a year to as much as $452 billion by 2015. Item

> Yale University researchers will study biomarkers for breast cancer in Hispanic women. More here

> The Michael J. Fox Foundation has a page of resources and a video on its Parkinson's Progression Markers Initiative. Site

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.